- Filed
- Mar 25, 2019 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2019 · Mar 22, 2019 | 105.74M sh |
| Cash And Equivalents | Q3 2019 · Jan 31, 2019 | $60.57K |
| Cash And Equivalents | Q3 2019 · Apr 30, 2018 | $111.82K |
| Stockholders Equity | Q3 2019 · Jan 31, 2019 | −$2.85M |
| Stockholders Equity | Q3 2019 · Apr 30, 2018 | −$1.47M |
| Current Liabilities | Q3 2019 · Jan 31, 2019 | $2.42M |
| Current Liabilities | Q3 2019 · Apr 30, 2018 | $1.06M |
| Total Liabilities | Q3 2019 · Jan 31, 2019 | $2.91M |
| Total Liabilities | Q3 2019 · Apr 30, 2018 | $1.56M |
| Current Assets | Q3 2019 · Jan 31, 2019 | $88.28K |
| Current Assets | Q3 2019 · Apr 30, 2018 | $139.29K |
| Total Assets | Q3 2019 · Jan 31, 2019 | $112.24K |
| Total Assets | Q3 2019 · Apr 30, 2018 | $152.3K |
| Rd Expense | Q3 2019 · Jan 31, 2019 | $124.3K |
| Rd Expense | Q3 2019 · Jan 31, 2019 | $365.71K |
| Rd Expense restated | Q3 2019 · Jan 31, 2018 | $204.41K |
| Rd Expense restated | Q3 2019 · Jan 31, 2018 | $603.19K |
| Capex | Q3 2019 · Jan 31, 2018 | $4.58K |
| Operating Cash Flow | Q3 2019 · Jan 31, 2018 | −$886.23K |
| Sga Expense restated | Q3 2019 · Jan 31, 2018 | $59.55K |
| Sga Expense restated | Q3 2019 · Jan 31, 2018 | $125.16K |
| Net Income | Q3 2019 · Jan 31, 2018 | −$672.25K |
| Net Income | Q3 2019 · Jan 31, 2018 | −$1.61M |
| Operating Income | Q3 2019 · Jan 31, 2018 | −$391.11K |
| Operating Income | Q3 2019 · Jan 31, 2018 | −$1.13M |